World's Best Scientists 2026 revealed!
Jennifer F Hoy

Jennifer F Hoy

D-Index & Metrics

Immunology

D-Index
62
Citations
25901
World Ranking
3087
National Ranking
130

Jennifer F Hoy publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jennifer F Hoy sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 303 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jennifer F Hoy D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jennifer F Hoy sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jennifer F Hoy is affiliated with Monash University in Australia and has a research focus predominantly within the field of Medicine, particularly in Infectious Diseases. Their scholarly output includes work across several subfields such as Emergency Medicine, Epidemiology, Virology, and Surgery.

The primary topics of Jennifer F Hoy's research revolve around HIV/AIDS, including HIV/AIDS research and interventions, HIV-related health complications and treatments, drug development and treatment for HIV/AIDS, and investigations into HIV, drug use, and sexual risk. Additional research interests cover Pneumocystis jirovecii pneumonia detection and treatment, as well as social issues related to sex work.

Jennifer F Hoy's recent notable publications include:

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, 2022, JAMA
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, 2020, JAMA
  • Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel, 2024, JAMA
  • HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults, 2021, Nature Medicine
  • Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents, 2021, AIDS

The venues where Jennifer F Hoy frequently publishes include:

  • AIDS
  • The Lancet HIV
  • JAMA
  • HIV Medicine
  • UNC Libraries

Collaborative research is an aspect of Jennifer F Hoy's work, with frequent co-authors including James McMahon, Christopher K. Fairley, Huldrych F. Günthard, David J. Templeton, and Kathy Petoumenos. These collaborations reflect a network of researchers engaged in the study and treatment of HIV and related health concerns.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • CD4+ count-guided interruption of antiretroviral treatment.

    Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.

    Unknown

  • Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

    Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim

  • Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study

    Benjamin R Bavinton;Angie N Pinto;Nittaya Phanuphak;Beatriz Grinsztejn

  • Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.

    S M Crowe;J B Carlin;K I Stewart;C R Lucas

  • Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

    Unknown

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

    Michael S. Saag;Rajesh T. Gandhi;Jennifer F. Hoy;Raphael J. Landovitz

  • Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.

    Michael W. Traeger;Vincent J. Cornelisse;Jason Asselin;Brian Price

  • Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

    Andrew Carr;Cassy Workman;Don E. Smith;Jennifer Hoy

  • Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

    Allison Martin;Don E Smith;Andrew Carr;Clare Ringland

  • New spectrum of fungal infections in patients with cancer.

    Elias Anaissie;Gerald P. Bodey;Hagop M Kantarjian;Jae Ro

  • Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of Aids-associated cryptococcal meningitis

    A.C.A.P. Leenders;P. Reiss;P. Portegies;K. Clezy

  • Continuous antiretroviral therapy decreases bone mineral density.

    Birgit Grund;Grace Peng;Cynthia L. Gibert;Jennifer F. Hoy

  • Quadruple-Drug Therapy for Mycobacterium avium-intracellulare Bacteremia in AIDS Patients

    Jennifer Hoy;Anne Mijch;Murray Sandland;Lindsay Grayson

  • Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

    Edwina Wright;Edwina Wright;Edwina Wright;B Grund;K Robertson;Bruce Brew;Bruce Brew

  • HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.

    Andrew M Carr;Jeff Hudson;John Chuah;Simon Mallal

  • Trichosporon beigelii infection: a review.

    Jennifer Hoy;Kuo Ching Hsu;Kenneth V Rolston;Roy L. Hopfer

  • Recommendations for Evaluation and Management of Bone Disease in HIV

    Todd T. Brown;Jennifer Hoy;Marco Borderi;Giovanni Guaraldi

  • HIV Infection and High Density Lipoprotein Metabolism

    Honor May Rose;Jennifer F Hoy;Jennifer F Hoy;Ian John Woolley;Ian John Woolley;Urbain Tchoua

Frequent Co-Authors

David A. Cooper
David A. Cooper University of New South Wales
Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Andrew Carr
Andrew Carr University of Oxford
Suzanne M. Crowe
Suzanne M. Crowe Burnet Institute
Christopher K. Fairley
Christopher K. Fairley Monash University
Matthew Law
Matthew Law University of New South Wales
Sean Emery
Sean Emery University of New South Wales
Margaret Hellard
Margaret Hellard Burnet Institute
Mark Stoove
Mark Stoove Burnet Institute
Allen C. Cheng
Allen C. Cheng Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their immunology knowledge and healthcare careers, exploring related nursing degrees and certifications can open new doors. Transitioning from a Family Nurse Practitioner (FNP) to specialize in more critical care roles is a strategic option, with options like acute care NP certification providing the necessary credentials.

Many students seek flexibility and speed in their education, which is why accelerated NP programs online have become popular. These programs offer an efficient path to becoming a nurse practitioner, aligning well with busy professionals’ schedules.

For individuals without a nursing background, pursuing an online degree can be less intimidating with online BSN programs for non nurses. These programs tailor the curriculum to support learners new to nursing while preparing them for clinical excellence.

Additionally, those seeking the quickest entry into nursing might consider options like the easiest ABSN program to get into. These accelerated programs focus on accessibility and fast-tracked training to meet the demand for qualified nurses swiftly.

Best Scientists Citing Jennifer F Hoy

Trending Scientists

Recently Published Articles